Document Detail

Pregnancy during hemodialysis: perinatal outcome in our cases.
MedLine Citation:
PMID:  15013299     Owner:  NLM     Status:  MEDLINE    
The perinatal outcome of patients undergoing chronic hemodialysis has been improved in recent years. In this report we review the treatment and outcome of seven pregnancies in women undergoing chronic hemodialysis before and during pregnancy between 2000 and 2002. The hemodialysis schedule was increased from 4 hours twice weekly to 4 hours four to six times weekly. Hemodialysis was performed using a high-flux dialyzer with volume-controlled ultrafiltration. The patients were followed in close collaboration between the obstetrician and the nephrologist. Monitoring of fetal well-being was started after 24 weeks' gestation, using cardiotocography by a nonstress test twice weekly and by weekly Doppler flow measurements. All patients underwent uterine contraction monitoring immediately after the dialysis. The mean gestational age at delivery was 32 weeks (range, 26 to 36 weeks). The causes of preterm delivery were premature contractions, premature rupture of membranes, preeclampsia, and intrauterine growth restriction. The outcomes were two pregnancies complicated by polyhydramnios and six pregnancies, that resulted in live births, all of whom survived. There was one neonatal death. The mean newborn birthweight was 1400 g (range, 420 to 2640 g) and the 1- and 5-minute Apgar scores ranged from 2/8 and 4/10, respectively one infant at 29-weeks gestation experienced respiratory distress syndrome but did well after 12 days. Cesarean section was performed in four pregnancies. The mothers were discharged on postoperative days 3 to 5. It is well known that the management of pregnant patients undergoing chronic hemodialysis is difficult. However, advances in dialysis, obstetrics, and neonatal care have improved the outcomes.
D Eroğlu; A Lembet; F N Ozdemir; T Ergin; F Kazanci; E Kuşcu; M Haberal
Related Documents :
17760989 - Measuring perinatal complications: methodologic issues related to gestational age.
18546079 - Prior cerclage: to repeat or not to repeat? that is the question.
9255079 - Ampicillin-metronidazole treatment in idiopathic preterm labour: a randomised controlle...
7936519 - The effect of indomethacin tocolysis on maternal coagulation status.
18814919 - Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous ...
9751939 - Laparoscopic cholecystectomy during pregnancy: a case series and review of the literature.
1336919 - Lupus anticoagulant and anticardiolipin antibodies in an obstetric population.
24813969 - The role of brain sparing in the prediction of adverse outcomes in intrauterine growth ...
12823999 - Plasma levels of the immunomodulatory cytokine interleukin-10 during normal human pregn...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  36     ISSN:  0041-1345     ISO Abbreviation:  Transplant. Proc.     Publication Date:    2004 Jan-Feb
Date Detail:
Created Date:  2004-03-11     Completed Date:  2004-10-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  53-5     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Baskent University, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / drug therapy,  etiology
Apgar Score
Birth Weight
Cesarean Section
Delivery, Obstetric
Erythropoietin / therapeutic use
Gestational Age
Infant, Newborn
Pregnancy Complications / physiopathology*
Pregnancy Outcome
Recombinant Proteins / therapeutic use
Renal Dialysis*
Retrospective Studies
Reg. No./Substance:
0/Recombinant Proteins; 11096-26-7/Erythropoietin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patie...
Next Document:  Efficacy and safety of sildenafil citrate in hemodialysis patients.